The Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, while a study of ...
Token efficiency takes centre stage with OpenAI’s latest family of AI models that supposedly outperform rival Anthropic’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results